Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride and dutasteride are not recommended for feminizing therapy due to limited effectiveness and potential risks.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Researchers created a new, efficient way to make Dutasteride, a hair loss and prostate drug, with high purity using a benzoyl group.

Finasteride may reduce prostate cancer risk.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Finasteride effectively reduces prostate size in dogs with benign prostatic hyperplasia at a low, safe dose.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

Bortezomib chemotherapy can cause temporary skin rashes.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Bimatoprost can help treat hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Clascoterone cream is a safer, effective acne treatment with fewer side effects.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Finasteride and flutamide can effectively treat hirsutism, with abdominal hairs showing the most sensitivity to the treatment.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

A man had bad reactions to a hair loss treatment called DNCB.